KURA Q1 2025 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M

Gross Profit

$14M100.0% margin

Operating Income

-$65M-458.6% margin

Net Income

-$57M-407.1% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

-73.8%

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$72M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$744M

Total Liabilities

$379M

Stockholders' Equity

$364M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$0	—
Gross Profit	$14M	-$234,000	+6129.1%
Operating Income	-$65M	-$54M	-18.8%
Net Income	-$57M	-$50M	-16.0%